ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Surescripts to Present New Data on Opportunities to Expand Access & Fill Gaps in Primary Care and More at NCPDP 2023 Annual Technology & Business Conference

Surescripts, the nation’s leading health information network, will lead two sessions at the National Council for Prescription Drug Programs (NCPDP) Annual Technology & Business Conference on May 9, 2023, on Opportunities to Expand Access & Fill Gaps in Primary Care and Improving Sig Clarity: Tools & Innovations for Improving the Prescription Experience in Healthcare.

“Engaging in conversations with industry leaders and organizations is key to understanding the biggest challenges facing healthcare today and how we can best support clinicians in addressing those challenges,” said Mark Gingrich, Chief Information Officer for Surescripts and NCPDP Board of Trustees Secretary/Treasurer. “It’s our job to equip clinicians, including our pharmacists, with the technology and information they need to ensure patients continue to have access to essential services such as immunizations, medication counseling and important health screenings and strengthening each clinician’s role within the patient care team.”

The first of two sessions, will focus on how advancing interoperability, new policies and payment models can help address some of healthcare’s top challenges like the predicted shortage of up to 124,000 physicians in the U.S. by 2034, proposing opportunities that may be available as 9 in 10 Americans live within five miles of a pharmacy.

Shannon Reidt, Director of Medication Research and Analytics at Surescripts, will present new data and analysis that supports the opportunity for evolving care teams, including pharmacists, to help fill gaps in primary care so patients will continue to have access to essential services.

Key report highlights:

  • Nearly half of all counties in the United States have relative shortages of primary care providers (PCPs), with just one PCP for every 1,500 people.
  • 61% of those counties also have a high volume of retail pharmacy locations that could help expand access to primary care where pharmacists could help address unmet patient needs -- with many in rural areas of the Midwest and South.

“We are encouraged by this new data that reinforces the incredible opportunity for pharmacists to work at the full scope of their license, complimenting the care delivered by primary care providers and leading to a more accessible care team for patients across the country,” said Melanie Marcus, Chief Marketing Officer for Surescripts and chair of the NCPDP Foundation’s National Advisory Council (NAC) strategic initiative: Role and Value of the Pharmacist. “This data also helps inform one of the NCPDP Foundation’s top priorities related to the role and value of the pharmacist as news of provider shortages and surmounting challenges threaten patient access to care.”

Reidt will also share important among primary care providers and non-primary care providers and how new policies including payment reform and advanced technology are needed to support the evolving care team.

Surescripts is a member and sponsor of NCPDP, supporting dozens of workgroups that inform leading pharmacy industry standards.

Where to Find Surescripts at NCPDP:

Speaking session: Opportunities to Expand Access & Fill Gaps in Primary Care, Tuesday, May 9, 3:10—3:30 p.m., in the Innovation Theater

Under intense pressure, today’s care team is evolving—and new data shows that pharmacies have a unique opportunity to improve access to primary care. We’ll dive into prescribing trends, geographic gaps, and where new policies, payment reform and technology are needed to help everyone work at the top of their license as one team.

Speaker: Shannon Reidt, Director, Medication Research and Analytics, Surescripts

Speaking session: Improving Sig Clarity: Tools & Innovations for Improving the Prescription Experience in Healthcare, Tuesday, May 9, 3:35—3:55 p.m. in the Innovation Theater

A Sig is the most variable part of a prescription. It’s also a top cause of confusion and clarification between healthcare providers. Learn about solutions and best practices that are helping reduce variability and standardize the Sig—ultimately streamlining the prescription process, enhancing communication and improving the healthcare experience.

Speaker: Scott Rochowiak, Manager, Product Performance, Surescripts

Meet with us in-person: visit us at booth 11 anytime during exhibit hours.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and give healthcare professionals the trusted insights they need to serve patients. We convene the Surescripts Network Alliance® to enhance prescribing, better inform care decisions and advance healthcare as a whole. Together, we’re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at surescripts.com and follow us at twitter.com/surescripts.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.16
-0.51 (-0.22%)
AAPL  277.55
+0.58 (0.21%)
AMD  214.24
+8.11 (3.93%)
BAC  52.99
+0.51 (0.97%)
GOOG  320.28
-3.36 (-1.04%)
META  633.61
-2.61 (-0.41%)
MSFT  485.50
+8.51 (1.78%)
NVDA  180.26
+2.44 (1.37%)
ORCL  204.96
+7.93 (4.02%)
TSLA  426.58
+7.18 (1.71%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.